This inventor holds 4 USPTO granted patents, plus 2 CIPO patents. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2012-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2018
Title: Reinhard Luehrmann: Innovator in RNA-Interference Technology
Introduction
Reinhard Luehrmann is a notable inventor based in Marburg-Michelbach, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of RNA-interference technology. With a total of four patents to his name, Luehrmann's work has had a profound impact on genetic research and therapeutic applications.
Latest Patents
Luehrmann's latest patents focus on the use of single-stranded RNA molecules for RNA-interference. His inventions detail the sequence and structural features of these RNA molecules that are essential for mediating target-specific nucleic acid modifications. This includes processes such as target mRNA degradation and DNA methylation, which are crucial for gene regulation and therapeutic interventions.
Career Highlights
Throughout his career, Reinhard Luehrmann has been associated with prestigious institutions, including the Max Planck Society for the Advancement of Science and the European Molecular Biology Laboratory. His work has not only advanced scientific understanding but has also paved the way for innovative treatments in genetic disorders.
Collaborations
Luehrmann has collaborated with prominent scientists in the field, including Thomas Tuschl and Javier Martinez. These collaborations have further enriched his research and contributed to the development of groundbreaking technologies in RNA biology.
Conclusion
Reinhard Luehrmann's contributions to RNA-interference technology exemplify the importance of innovation in molecular biology. His patents and collaborations continue to influence the scientific community and drive advancements in genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
